Decreased serum levels of α-synuclein in patients with schizophrenia and their unaffected siblings.

Diğdem GövertiNihan BüyüklüoğluRabia Nazik YükselHasan KayaÇiğdem YücelErol Göka

Published in: Early intervention in psychiatry (2023)

Our study demonstrates that decreased levels of serum α-synuclein may be utilized as a possible peripheral biomarker of familial risk for schizophrenia in both patients and their siblings.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
intellectual disability
bipolar disorder
peritoneal dialysis
prognostic factors
early onset
autism spectrum disorder
patient reported